The prognosis ofMYCtranslocation positive diffuse large B-cell lymphoma depends on the second hit-Reference-Cited by-同舟云学术

The prognosis ofMYCtranslocation positive diffuse large B-cell lymphoma depends on the second hit

Published:2015-03-30 Issue:3 Volume:1 Page:125-133
ISSN:2056-4538
Container-title:The Journal of Pathology: Clinical Research
language:en
Short-container-title:J Path: Clin Res

Author:

Clipson Alexandra¹,Barrans Sharon²,Zeng Naiyan¹,Crouch Simon³,Grigoropoulos Nicholas F¹⁴,Liu Hongxiang⁵,Kocialkowski Sylvia¹,Wang Ming¹,Huang Yuanxue¹,Worrillow Lisa²,Goodlad John⁶,Buxton Jenny⁷,Neat Michael⁸,Fields Paul⁹,Wilkins Bridget¹⁰,Grant John W⁵,Wright Penny⁵,EI-Daly Hesham⁴,Follows George A⁴,Roman Eve³,Watkins A James⁴,Johnson Peter W M¹¹,Jack Andrew²,Du Ming-Qing¹⁵

Affiliation:

1. Division of Molecular Histopathology; Department of Pathology; University of Cambridge; UK

2. Haematological Malignancy Diagnostic Service; St. James's Institute of Oncology; Leeds UK

3. Department of Health Sciences; Epidemiology and Cancer Statistics Group; University of York; York UK

4. Department of Haematology; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust; Cambridge UK

5. Department of Histopathology; Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust; Cambridge UK

6. Department of Pathology; Western General Hospital; Edinburgh UK

7. Department of Haematology; Western General Hospital; Edinburgh UK

8. Department of Haematology and Department of Cytogenetics; GSTS Pathology; Guy's and St. Thomas NHS Foundation Trust; London UK

9. Department of Haematology GSST; Kings Health Partners; London UK

10. Histopathology Department; St Thomas' Hospital and King's College; London UK

11. Cancer Research UK Centre; University of Southampton; Southampton United Kingdom

Funder

Leukemia lymphoma Research

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference38 articles.

1. Second-line treatment paradigms for diffuse large B-cell lymphomas;Thieblemont;Curr Oncol Rep,2009

2. Poor concordance among nine immunohistochemistry classifiers of cell-of-origin for Diffuse Large B-cell Lymphoma: implications for therapeutic strategies;Coutinho;Clin Cancer Res,2013

3. Whole genome expression profiling based on paraffin embedded tissue can be used to classify diffuse large B-cell lymphoma and predict clinical outcome;Barrans;Br J Haematol,2012

4. Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue;Scott;Blood,2014

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High-grade B-cell lymphoma with a quadruple-hit genetic profile including concurrent MYC, BCL2, BCL6, and CCND1 gene rearrangements;Laboratory Medicine;2024-03-24

2. Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential;Leukemia;2024-01-06

3. The fifth edition of the WHO classification of mature B‐cell neoplasms: open questions for research;The Journal of Pathology;2024-01-05

4. Anti-CD20 antibody treatment for diffuse large B cell lymphoma: Genetic alterations and signaling pathways;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024

5. Non-IG::MYC in diffuse large B-cell lymphoma confers variable genomic configurations and MYC transactivation potential;2023-10-09